Minerva Neurosciences Inc reports results for the quarter ended June 30 - Earnings Summary

Minerva Neurosciences

15/08/2025 14:31

Minerva Neurosciences Inc NERV.OQ reported a quarterly adjusted loss of 43 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.09.  The lone analyst forecast for the quarter was for a loss of 90 cents per share.

Reported revenue was zero​; analysts expected zero.

Minerva Neurosciences Inc's reported EPS for the quarter was a loss of 43 cents​.

Minerva Neurosciences Inc shares had risen by 4.4% this quarter and lost 19.2% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts was unchanged in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is  "buy."

This summary was machine generated from LSEG data August 15 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
-0.90
-0.43
Beat
Mar. 31 2025
-1.07
-0.50
Beat
Dec. 31 2024
-1.05
-0.56
Beat
Sep. 30 2024
-1.01
-0.54
Beat